You are here: Industry Insights > Danaher

News List

Danaher To Acquire Aldevron for $9.6B contractpharma
June 22, 2021
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
Danaher to acquire Aldevron from EQT for $9.6bn pharmaceutical-business-review
June 18, 2021
Danaher, a science and technology company, has agreed to acquire biotech firm Aldevron from EQT Private Equity for an enterprise value of $9.bn.
Precision NanoSystems joins Danaher's Life Sciences Platform firstwordpharma
June 02, 2021
Precision NanoSystems (PNI) has been acquired by Danaher Corporation's Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics.
Sartorius Completes $825M Acquisition of Danaher Businesses contractpharma
May 04, 2020
Expands market position in bioanalytics and key areas of the manufacture of biopharmaceuticals.
GE to divest its Biopharma business to Danaher for $21.4bn pharmaceutical-technology
February 27, 2019
US-based conglomerate General Electric (GE) has entered into a definitive agreement to divest its Biopharma business to science and technology innovator Danaher for approximately $21.4bn.
Danaher to Acquire Integrated DNA Technologies biospace
March 12, 2018
Danahe and Integrated DNA Technologies announced today that Danaher has entered into a definitive agreement to acquire IDT